HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 29 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,000 | -50.0% | 22,700 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | +128.6% | 22,700 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -56.2% | 22,700 | 0.0% | 0.00% | – |
| Q4 2019 | $16,000 | -27.3% | 22,700 | -30.2% | 0.00% | – |
| Q3 2019 | $22,000 | -58.5% | 32,507 | +2.0% | 0.00% | – |
| Q2 2019 | $53,000 | -65.6% | 31,862 | -48.4% | 0.00% | – |
| Q1 2019 | $154,000 | +2.0% | 61,796 | +4.0% | 0.00% | – |
| Q4 2018 | $151,000 | +31.3% | 59,438 | +161.8% | 0.00% | – |
| Q3 2018 | $115,000 | +55.4% | 22,700 | 0.0% | 0.00% | – |
| Q2 2018 | $74,000 | -9.8% | 22,700 | 0.0% | 0.00% | – |
| Q1 2018 | $82,000 | -76.2% | 22,700 | -54.4% | 0.00% | – |
| Q1 2017 | $345,000 | – | 49,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,689,064 | $5,506,000 | 3.35% |
| PERKINS CAPITAL MANAGEMENT INC | 249,700 | $814,000 | 0.58% |
| Private Wealth Partners, LLC | 900,000 | $2,934,000 | 0.49% |
| Diametric Capital, LP | 60,752 | $198,000 | 0.19% |
| Granahan Investment Management | 915,449 | $2,984,000 | 0.18% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $815,000 | 0.11% |
| Kalos Management, Inc. | 38,000 | $137,000 | 0.06% |
| Spark Investment Management LLC | 203,600 | $663,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 199,500 | $650,000 | 0.03% |
| Crow Point Partners, LLC | 25,860 | $84,000 | 0.02% |